IMMUNOCHEMICAL AND PHYSICAL-CHEMICAL EVIDENCE FOR THE PRESENCE OF THYMOSIN ALPHA1-PEPTIDE IN DIALYZABLE LEUKOCYTE EXTRACTS

Abstract

This chapter presents immunochemical and physical–chemical evidence for the presence of thymosin alpha1-peptide in dialyzable leukocyte extracts (DLE). In a study described in the chapter, the collective results obtained from immunologic and physical–chemical evaluations of the E-receptor regeneration promoting activity present in human DLE indicate that it is partly because of the presence of thymosin α1 peptide in DLE. There are, however, additional components in DLE that express a similar activity but do not seen to be intact thymosin α1. Included here might be thymic humoral factor, which has a pi of 5.7 and could be responsible for the activity found in the β region when DLE Sephadex G-25 Fraction IV was fractionated by IEP in a 2.5 to 10 gradient.The documentation of the presence of a variety of T-lymphocyte maturation or differentiation factors in DLE explains why DLE may have nonspecific beneficial effects when it is employed as an immunotherapeutic agent.